Hizartzidis, L.; Tarleton, M.; Gordon, C. P.; McCluskey, A.; RSC Adv., 2014, 4, 9709-9722
Eco-efficiency analysis for intensified production of an active pharmaceutical ingredient: a case study
Dencic, I.; Ott, D.; Kralisch, D.; Noel, T.; Meuldijk, J.; de Croon, M.; Hessel, V.; Laribi, Y.; Perrichon, P.; Org. Process Res. Dev., 2014, 18(11), 1326-1338
From the Lindlar catalyst to supported ligand‐modified palladium nanoparticles: selectivity patterns and accessibility constraints in the continuous‐flow three‐phase hydrogenation of acetylenic compounds
Vile, G.; Almora-Barrios, N.; Mitchell, S.; Lopez, N.; Perez-Ramirez, J.; Chem. Eur. J., 2014, 20, 5926-5937
Green and scalable procedure for extremely fast ligandless Suzuki-Miyaura cross-coupling reactions in aqueous IPA using solid-supported Pd in continuous flow
Mateos, C.; Rincon, J. A.; Martin-Hidalgo, B.; Villanueva, J.; Tetrahedron Letters, 2014, 55(27), 3701-3705
Integration of enabling methods for the automated flow preparation of piperazine-2-carboxamide
Ingham, R. J.; Battilocchio, C.; Hawkins, J. M.; Ley, S. V.; Beilstein J. Org. Chem., 2014, 10, 641-652
Synthesis, structure–activity, and structure–stability relationships of 2‐substituted‐N‐(4‐oxo‐3‐oxetanyl) N‐acylethanolamine acid amidase (NAAA) inhibitors
Vitale, R.; Ottonello, G.; Petracca, R.; Bertozzi, S. M.; Ponzano, S.; Armirotti, A.; Berteotti, A.; Dionisi, M.; Cavalli, A.; Piomelli, D.; Bandiera, T.; Bertozzi, F.; ChemMedChem, 2014, 9, 323-336
Synthesis, antitubulin, and antiproliferative SAR of C3/C1‐substituted tetrahydroisoquinolines
Dohle, W.; Leese, M. P.; Jourdan, F. L.; Major, M. R.; Bai, R.; Hamel, E.; Ferrandis, E.; Kasprzyk, P. G.; Fiore, A.; Newman, S. P.; Purohit, A.; Potter, B. V. L.; ChemMedChem, 2014, 9, 350-370
Titanium nitride-nickel nanocomposite as heterogeneous catalyst for the hydrogenolysis of aryl ethers
Molinari, V.; Giordano, C.; Antonietti, M.; Esposito, D.; J. Am. Chem. Soc., 2014, 136(5), 1758-1761
Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons
Belema, M.; Nguyen, V. N.; Romine, J. L.; St. Laurent, D. R.; Lopez, O. D.; Goodrich, J. T.; Nower, P. T.; O’Boyle, D. R.; Lemm, J. A.; Fridell, R. A.; Gao, M.; Fang, H.; Krause, R. G.; Wang, Y.; Oliver, A. J.; Good, A. C.; Knipe, J. O.; Meanwell, N. A.; Snyder, L. B.; J. Med. Chem., 2014, 57, 1995-2012
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulators
Pettersson, M.; Johnson, D. S.; Subramanyam, C.; Bales, K. R.; am Ende, C. W.; Fish, B. A.; Green, M. E.; Kauffman, G. W.; Mullins, P. B.; Navaratnam, T.; Sakya, S. M.; Stiff, C. M.; Tran, T. P.; Xie, L.; Zhang, L.; Pustilnik, L. R.; Vetelino, B. C.; Wood, K. M.; Pozdnyakov, N.; Verhoest, P. R.; O’Donnell, C. J.; J. Med. Chem., 2014, 57, 1046-1062